JONBUR Research · Initiation
MDS Tech · 086960 · Software
MDS Tech: Thin-Margin Software Firm Trades Below Book Value After Profit Recovery and a Robot-Order Headline
Why this report
Start of coverage: written when a reader opened this company and there was no report yet.
MDS Tech closed at ₩2,300 on 2026-10-20, up 16.3% over one month but down 34.0% over one year, with a market value of about ₩97.8B. Trailing profit has improved to ₩19.7B of net income, and the stock trades at 5.0x earnings and 0.6x book value.
Written Oct 21, 2026 · Data as of Oct 20, 2026 · 0 views
This is not financial advice. The report does not recommend buying or selling anything.
Thesis
The data supports a recovery story in the numbers. Revenue has grown for three straight years, and trailing net income of ₩19.7B is well above the ₩8.2B reported for 2025. ROE has risen to 13.6% from 6.1%. The balance sheet looks manageable, with cash of ₩49.3B against borrowings of ₩14.9B.
The data does not show that earnings quality is high. Trailing operating income is only ₩11.2B, which is a 5.4% margin, while net income is larger at ₩19.7B. The filings provided do not explain the gap, so it cannot be attributed to any cause. Free cash flow is ₩4.8B, far below net income.
The latest headlines say a ₩4B order for humanoid home robot AI hardware was announced on 2026-10-20. That is about 1.9% of trailing revenue. The data gives no timing, margin or follow-on volume for the order. Recent filings on convertible bonds (conversion rights exercised, a call option exercised by a third party, and a conversion price adjustment) point to possible share dilution, though the data does not give the size.
Business overview
MDS Tech is a KOSDAQ-listed software company, founded on 1998-12-29 and listed on 2006-09-26. It has 42,528,670 listed shares and a market capitalization of about ₩97.8B. Co-CEOs are listed as Lee Chang-yeol and Lee Jung-seung.
Revenue was ₩155.1B in 2021 and ₩187.7B in 2025. Growth was flat to slightly negative in 2022, then 1.2% in 2023, 6.6% in 2024 and 13.4% in 2025. Trailing revenue to H1 2026 is ₩207.7B. The data does not break revenue down by product or customer.
Financial analysis
The figures below come from filed financial statements. Revenue rose from ₩165.6B in 2024 to ₩187.7B in 2025, and trailing revenue to H1 2026 is ₩207.7B.
Operating income was ₩5.8B in 2025 (3.1% margin), ₩5.9B in 2024 (3.6%) and ₩8.7B in 2023 (5.6%). The trailing figure is ₩11.2B, or 5.4%. Net income was a loss of ₩6.8B in 2022, ₩1.4B in 2023, ₩6.9B in 2024 and ₩8.2B in 2025. Trailing net income is ₩19.7B, a 9.5% net margin. ROE moved from -6.3% in 2022 to 6.1% in 2025 and 13.6% trailing.
Liabilities to equity are 41.8%. Cash is ₩49.3B and borrowings are ₩14.9B. Trailing free cash flow is ₩4.8B, much lower than reported net income.
Valuation
At ₩2,300 the stock trades at 5.0x earnings, 0.6x book value and 0.5x sales. Enterprise value is about ₩63.4B. No dividend yield is shown (0.0%), and EV/EBITDA is not available. Year-end P/B was 1.0x in 2025, 0.8x in 2024 and 1.5x in 2023. Year-end P/E was 16.8x in 2025 and 15.3x in 2024, so the current 5.0x is below those levels.
Peers in the data show a wide range. P/E runs from 7.3x (Netmarble) to 48.4x (Hyundai Autoever), and P/B from 0.5x (Netmarble) to 4.9x (Hyundai Autoever). MDS Tech's 5.0x P/E is below all five listed peers, and its 0.6x P/B is above only Netmarble's 0.5x. The peers are far larger, with market caps of ₩2.1T to ₩9.2T.
The valuation model uses a 5-year discounted cash flow at a 12.1% rate on trailing figures to H1 2026. It gives a model estimate based on the assumptions shown of ₩2,211 per share in the base case, ₩1,348 in the bear case and ₩3,514 in the bull case. The base case is about 3.9% below the ₩2,300 close, and the price sits between the base and bull cases. This is not a target or a reason to buy or sell. The 52-week low in the data is shown as ₩0, which looks like a data gap, and the 52-week high is about ₩4,554.
Catalysts
- Headlines on 2026-10-20 report a ₩4B order to supply Nvidia Jetson-based AI hardware for humanoid home robots, and Edaily describes it as the start of full-scale revenue from the physical AI business.
- The amended half-year report filed on 2026-09-30 updated the latest reported financials, so further revisions or the next quarterly report could shift the trailing numbers.
- Convertible bond activity, including the conversion price adjustment on 2026-08-20 and conversion rights exercised on 2026-05-21, may change the share count and capital structure.
- Shareholding filings, including 5%+ holding reports on 2026-06-29 and 2026-07-10 and insider reports, show ownership changes worth watching.
- Share price momentum is positive, with gains of 16.3% in one month and 27.1% in three months, though the one-year return is still -34.0%.
Risks
- Operating margin is thin at 5.4% trailing and was 3.1% in 2025, leaving profit sensitive to cost or pricing changes.
- Net income of ₩19.7B exceeds operating income of ₩11.2B, and free cash flow is only ₩4.8B, so the quality of earnings is uncertain.
- Convertible bond conversions and a conversion price adjustment could dilute existing shareholders.
- The ₩4B robot order is small relative to ₩207.7B of trailing revenue, and its profitability and repeat potential are not in the data.
- Foreign investors sold about ₩1.8B over 20 days and foreign ownership fell to 1.6% from 1.9% sixty days earlier, and a trading halt filing on 2026-05-07 shows past volatility.
Closing view
The data shows a company whose revenue and profit have improved, with ROE at 13.6% and a valuation of 0.6x book and 5.0x earnings, below the listed peers on P/E. The model estimate of ₩2,211 per share in the base case is close to the current price, with a wide range of ₩1,348 to ₩3,514. Against that, margins are thin, cash conversion is weak, convertible bond activity may dilute shares, and the new robot order is small and not yet proven as a growth driver. The evidence is mixed and leaves room for different interpretations.
Model estimate of fair value
- Bear
- ₩1,348
- -39%
- Base
- ₩2,211
- -1%
- Bull
- ₩3,514
- +58%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Base case of the 5-year discounted cash flow model on the stock's Valuation tab (statements TTM to H1 2026; discount rate 12.1%). Bear and Bull move the main assumptions by fixed steps. See and change the assumptions
Filings and data used
- Amended: Half-year report (Jun 2026)Sep 30, 2026
- Adjustment of Conversion PriceAug 20, 2026
- Added attachment: Half-year report (Jun 2026)Aug 14, 2026
- 5%+ holding reportJul 10, 2026
- Insider shareholding reportJun 29, 2026
- 5%+ holding reportJun 29, 2026
- Major Matters Report (Exercise of Convertible Bond Call Option by Third Party)Jun 5, 2026
- Exercise of Conversion RightsMay 21, 2026
- Quarterly report (Mar 2026)May 15, 2026
- Insider shareholding reportMay 8, 2026
- Trading haltMay 7, 2026
- Change of Department AffiliationApr 30, 2026
- MDS Tech to Supply Nvidia AI Chips Worth ₩4B for Humanoid RobotsOct 20, 2026
- MDS Tech Supplies KRW 4B Jetson Package for Humanoid Home RobotsOct 20, 2026
- MDS Tech begins full-scale revenue generation from physical AI businessOct 20, 2026
- MDS Tech Supplies NVIDIA AI Platform for Humanoid Home Robot, Wins ₩4B OrderOct 20, 2026
- Daily prices up to 2026-10-20
- Financial statements, trailing 12 months as of H1 2026
- Our fair value model, statements as of TTM to H1 2026
Report history
Source: KRX statistical information